Murray A Goldberg's Net Worth
$184 Million
Estimate Recalculated Nov 7, 2024 11:33AM EST
Who is Murray A Goldberg?
Murray A Goldberg has an estimated net worth of $184 Million. This is based on reported shares across multiple companies, which include TEVA PHARMACEUTICAL INDUSTRIES LTD, AERIE PHARMACEUTICALS INC, REGENERON PHARMACEUTICALS INC, Ayala Pharmaceuticals, Inc., and Ayala Pharmaceuticals, Inc..
SEC CIK
Murray A Goldberg's CIK is 0001226435
Past Insider Trading and Trends
2011 was Murray A Goldberg's most active year for acquiring shares with 21 total transactions. Murray A Goldberg's most active month to acquire stocks was the month of November. 2012 was Murray A Goldberg's most active year for disposing of shares, totalling 72 transactions. Murray A Goldberg's most active month to dispose stocks was the month of December. 2014 saw Murray A Goldberg paying a total of $6,320,326.73 for 217,643 shares, this is the most they've acquired in one year. In 2014 Murray A Goldberg cashed out on 286,952 shares for a total of $50,808,458.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Snapshot price: $18.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +347.83% | 28K |
$3.15 | $88,200.00 | 36.05K |
May 18
| |||
Form 4
| +27.78% | 1.75K |
—
|
—
| 8.05K |
May 23
| |||
Form 4
| +38.46% | 1.75K |
—
|
—
| 6.3K |
Jun 7
| |||
Form 4
| +33.82% | 1.15K |
—
|
—
| 4.55K |
Jun 8
| |||
Form 4
| +100.00% | 1.7K |
—
|
—
| 3.4K |
Jun 8
| |||
Form 4
|
∞
| 1.7K |
—
|
—
| 1.7K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REGENERON PHARMACEUTICALS INC (REGN) Snapshot price: $1131.5
SVP Administration & Asst Secr
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.11% | 1.33K |
$30.63 | $99,976.32 | 64.44K |
Nov 17 - Dec 16
| |||
Form 4
|
—
|
0
|
$213.24 | -$21,912,996.70 | 63.1K |
Scheduled
|
Oct 23 - Oct 24
| ||
Form 4
|
—
|
0
|
$203.16 | -$8,358,393.52 | 63.1K |
Scheduled
|
Feb 24 - Feb 25
| ||
Form 4
|
—
|
0
|
$189.12 | -$14,316,717.38 | 63.1K |
Scheduled
|
Feb 20 - Feb 21
| ||
Form 4
| +8.06% | 4.71K |
$21.25 | $99,981.25 | 63.1K |
Dec 18
| |||
Form 4
| -8.11% | -5.16K |
$272.73 | -$1,406,468.61 | 58.4K |
Scheduled
|
Dec 13 - Dec 16
| ||
Form 4
| +8.54% | 5K |
$16.80 | $84,000.00 | 63.55K |
Aug 1
| |||
Form 4
| -53.30% | -66.83K |
$259.74 | -$17,359,652.41 | 58.55K |
Scheduled
|
May 20 - May 21
| ||
Form 4
| +114.00% | 66.8K |
$143.32 | -$18,592,471.34 | 125.39K |
Scheduled
|
May 20 - May 21
| ||
Form 4
| -11.85% | -7.88K |
$172.16 | -$1,356,272.06 | 58.59K |
Scheduled
|
Jan 16
| ||
Form 4
| -19.95% | -16.76K |
$99.73 | -$787,659.91 | 67.22K |
Scheduled
|
Nov 21 - Dec 17
| ||
Form 4
| -7.22% | -6.54K |
$94.49 | -$1,825,325.20 | 83.98K |
Scheduled
|
Nov 13 - Nov 14
| ||
Form 4
| -6.12% | -5.90K |
$145.89 | -$772,607.95 | 90.51K |
Scheduled
|
Jul 27 - Aug 31
| ||
Form 4
| +20.26% | 16.24K |
$14.53 | $235,977.52 | 96.41K |
May 21
| |||
Form 4
| -7.97% | -6.95K |
$78.90 | -$7,146,796.00 | 80.17K |
Scheduled
|
May 2 - May 3
| ||
Form 4
|
—
|
0
|
$59.64 | -$3,215,596.81 | 87.11K |
Scheduled
|
Feb 6 - Feb 7
| ||
Form 4
| -2.52% | -2.25K |
$55.83 | -$3,079,836.24 | 87.11K |
Scheduled
|
Jan 26 - Feb 1
| ||
Form 4
|
—
|
0
|
$49.60 | -$2,388,729.35 | 89.36K |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
| +2.88% | 2.5K |
$11.64 | $29,100.00 | 89.36K |
Dec 16 - Dec 20
| |||
Form 4
| -5.05% | -4.62K |
$51.18 | -$236,553.96 | 86.86K |
Scheduled
|
Dec 14
| ||
Form 4
| +17.69% | 13.75K |
$11.03 | $151,712.13 | 91.48K |
Oct 4
| |||
Form 4
| -5.13% | -4.20K |
$67.00 | -$281,400.00 | 77.73K |
Scheduled
|
Sep 21
| ||
Form 4
| +5.40% | 4.2K |
$41.29 | -$1,243,899.78 | 81.93K |
Scheduled
|
Sep 8 - Sep 9
| ||
Form 4
|
—
|
0
|
$41.43 | -$1,708,067.92 | 77.73K |
Scheduled
|
Sep 6 - Sep 7
| ||
Form 4
|
—
|
0
|
$34.17 | -$676,069.45 | 77.73K |
Scheduled
|
Aug 15 - Aug 16
| ||
Form 4
|
—
|
0
|
$31.68 | -$974,774.81 | 77.73K |
Scheduled
|
Jul 27 - Jul 28
| ||
Form 4
|
—
|
0
|
$28.52 | -$269,767.71 | 77.73K |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
|
—
|
0
|
$27.93 | -$339,986.60 | 77.73K |
Scheduled
|
Feb 11 - Feb 14
| ||
Form 4
|
—
|
0
|
$24.09 | -$392,683.89 | 77.73K |
Scheduled
|
Jan 6 - Jan 7
| ||
Form 4
| +5.42% | 4K |
$9.49 | $37,960.00 | 77.73K |
Dec 23
| |||
Form 4/A
| +68.60% | 30K |
—
|
—
| 73.73K |
Dec 14
| |||
Form 4
|
—
|
0
|
$22.46 | -$307,308.80 | 43.73K |
Scheduled
|
Dec 16 - Dec 17
| ||
Form 4
|
—
|
0
|
$22.46 | -$307,308.80 | 43.73K |
Scheduled
|
Dec 16 - Dec 17
| ||
Form 4
|
—
|
0
|
$21.34 | -$333,442.05 | 43.73K |
Scheduled
|
Jun 3 - Jun 4
| ||
Form 4
|
—
|
0
|
$19.93 | -$312,248.82 | 43.73K |
Scheduled
|
Feb 3 - Feb 4
| ||
Form 4
| -22.52% | -12.71K |
$24.88 | -$316,234.98 | 43.73K |
Scheduled
|
Jan 6
| ||
Form 4
| +34.15% | 14.37K |
$17.34 | -$198,954.46 | 56.44K |
Scheduled
|
Jan 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +12.40% | 4.64K |
$8.77 | $40,719.11 | 42.07K |
Oct 29
| |||
Form 4
| +3.60% | 1.3K |
$7.41 | $9,633.00 | 37.43K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +4.57% | 1.58K |
$7.41 | $12,597.00 | 36.13K |
Dec 8 - Dec 15
| |||
Form 4
| -0.58% | -200.00 |
—
|
—
| 34.55K |
Dec 17
| |||
Form 4
|
—
|
0
|
$17.93 | -$364,081.62 | 38.78K |
Scheduled
|
Apr 25 - Apr 26
| ||
Form 4
|
—
|
0
|
$17.33 | -$188,193.03 | 38.78K |
Scheduled
|
Apr 20 - Apr 23
| ||
Form 4
|
—
|
0
|
$16.74 | -$123,644.16 | 38.78K |
Scheduled
|
Apr 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +9.94% | 3.47K |
$16.05 | -$19,356.30 | 38.37K |
Scheduled
|
Nov 20
| ||
Form 4
| -7.34% | -2.77K |
$23.67 | -$65,435.40 | 34.9K |
Scheduled
|
Nov 6 - Nov 8
| ||
Form 4
| +7.31% | 2.56K |
$15.94 | -$506,474.08 | 37.66K |
Scheduled
|
Aug 21 - Nov 8
| ||
Form 4
| -5.96% | -2.18K |
$17.33 | -$37,735.21 | 34.34K |
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
$13.00 | -$14,888.88 | 36.52K |
Scheduled
|
Dec 23 - Dec 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
| -5.63% | -2.18K |
$10.00 | -$21,770.00 | 36.52K |
Scheduled
|
Jul 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +30.01% | 8.8K |
$5.63 | $49,500.00 | 38.13K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| -7.03% | -2.19K |
$15.33 | -$33,551.95 | 28.92K |
Scheduled
|
Jan 9
| ||
Form 4
| +38.88% | 8.71K |
—
|
—
| 31.11K |
Dec 15
| |||
Form 4
| -18.55% | -5.10K |
$14.08 | -$239,098.13 | 22.4K |
Sep 16 - Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Scheduled
| |||
| No matching records found | |||||||||
Ayala Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ayala Pharmaceuticals, Inc. (ADXS) Snapshot price: $0.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||